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Introduction
Parasites are organisms that live on or in another organ-
ism—the host—from which they extract some or all of
their nourishment and in doing so, cause harm. Figuring
out why parasites harm their hosts when they completely
rely on hosts for survival has long challenged evolutionary
biologists. A favored evolutionary hypothesis to explain
parasite virulence (see Glossary for deﬁnition of key
terms) is the adaptive trade-off hypothesis, which assumes
that virulence arises as an unavoidable by-product of host
resource exploitation which is needed to maximize the
parasite’s Darwinian ﬁtness. Under this framework, para-
sites which are good ‘exploiters’ are expected to produce
more transmission-stage parasites over the duration of
infection, with death via over-exploitation the ﬁtness cost
limiting virulence evolution (Anderson and May 1982;
Ewald 1983; Read 1994; Ebert and Herre 1996; Frank
1996). The trade-off hypothesis has received empirical
support; positive relationships between virulence and
transmission have been found for many (for example,
Meunier et al. 1985; Mackinnon and Read 1999a; Paul
et al. 2004; Masumu et al. 2006; Fraser et al. 2007;
Mackinnon et al. 2008; de Roode et al. 2008), but not all
host-pathogen systems (Lipsitch and Moxon 1997; Jakel
et al. 2001; Medica and Sukhdeo 2001; Ebert and Bull
2003) and direct evidence to support parasite-induced
host mortality acting as a brake on virulence evolution is
rare (Fenner and Ratcliffe 1965; Mackinnon et al. 2002).
For an excellent comprehensive review of the trade-off
hypothesis, including current debates in the ﬁeld, see
(Alizon et al. 2009).
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Abstract
Evolutionary theories explaining virulence—the ﬁtness damage incurred by
infected hosts—often focus on parasite strategies for within-host exploitation.
However, much virulence can be caused by the host’s own immune response:
for example, pro-inﬂammatory cytokines, although essential for killing malaria
parasites, also damage host tissue. Here we argue that immune-mediated viru-
lence, or ‘immunopathology,’ may affect malaria virulence evolution and
should be considered in the design of medical interventions. Our argument is
based on the ability of immunopathology to disrupt positive virulence-
transmission relationships assumed under the trade-off theory of virulence
evolution. During rodent malaria infections, experimental reduction of inﬂam-
mation using reagents approved for ﬁeld use decreases virulence but increases
parasite transmission potential. Importantly, rodent malaria parasites exhibit
genetic diversity in the propensity to induce inﬂammation and invest in trans-
mission-stage parasites in the presence of pro-inﬂammatory cytokines. If
immunopathology positively correlates with malaria parasite density, theory
suggests it could select for relatively low malaria virulence. Medical interven-
tions which decrease immunopathology may therefore inadvertently select for
increased malaria virulence. The ﬁtness consequences to parasites of variations
in immunopathology must be better understood in order to predict trajectories
of parasite virulence evolution in heterogeneous host populations and in
response to medical interventions.
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empirical support may arise is because the trade-off
hypothesis, until recently (Day et al. 2007; Alizon et al.
2009), did not incorporate parasite-induced immune-med-
iated virulence, or immunopathology. Here, with a speciﬁc
focus on malaria, we summarize empirical evidence that
immunopathology may shape parasite evolution, with
applied consequences. We begin by giving a brief introduc-
tion of the malaria life-cycle and immune response to
infection. We then describe theoretical work which has
extended basic trade-off theory to include certain aspects of
the host immune response, including immunopathology.
Finally, we outline experimental studies investigating the
selective effects of immunopathology on evolution of
malaria parasite virulence and discuss the public health
implications of results in light of theoretical predictions.
The remarkable capacity of Plasmodium parasites to
adapt, survive and transmit within heterogeneous host
populations (Mackinnon and Marsh 2010) goes a long
way to explain the success of these parasites, as well as
the crippling effect malaria exerts on humanity (Snow
et al. 2005). The life-cycle of Plasmodium parasites is
complex, consisting of alternating phases in the mosquito
vector and the vertebrate host. For a detailed schematic
of the Plasmodium lifecycle as well as an overview of
immune responses to malaria see (Stevenson and Riley
2004). In order to be transmitted to mosquitoes, asexual
Plasmodium parasites replicating in the red blood cells
(RBCs) of a vertebrate host must produce sexual stages
(male and female gametocytes). A subset of asexual para-
sites commit to gametocyte production, so increasing
asexual parasite density is expected to correlate with
transmission success. Thus in the case of malaria, trade-
off theory predicts that the most evolutionarily successful
parasite would be one which maximizes gametocyte pro-
duction and infection length while avoiding host death
and immune clearance. Indeed, studies using the Plasmo-
dium chabaudi rodent model of malaria infection support
several key assumptions of the trade-off hypothesis
(Mackinnon and Read 2004a). Speciﬁcally, parasite geno-
types which inﬂict the greatest virulence (see Glossary for
key traits measured in this malaria model system) enjoy
higher transmissibility and, in the absence of host death,
longer infectious periods (Mackinnon and Read 1999a,b,
Glossary Key Terms and Examples of Empirical Measurements
Deﬁnition What can be measured in a rodent malaria model of infection
Parasite We use this term to encompass both micro- and
macro-parasites.
Plasmodium chabaudi chabaudi.
Virulence Any harm to host following infection. Theoretical
models frequently deﬁne virulence as the rate of
host mortality. Empirical studies often use
morbidity measures as a proxy for host death.
Case fatality rates in some experiments. In others, maximum
loss of weight, temperature, or red blood cells during
infection, which positively correlate with host death
(Timms et al. 2001; Mackinnon et al. 2002;
Ferguson et al. 2003).
Transmission
Potential
Number of transmission-stage parasites produced
during the life-time of infection. Otherwise
referred to as the parasites’ Darwinian ﬁtness.
Cumulative or peak number of sexual parasites (gametocytes),
duration of gametocyte positivity (days gametocyte positive),
and/or infectivity to mosquitoes. Cumulative gametocyte
density is determined by the rate of gametocyte production
and is an excellent indicator of lifetime transmission potential
as well as transmission to mosquitoes (Taylor and Read 1997;
Mackinnon and Read 1999a; Buckling and Read 2001).
Immunopathology Harm to host tissue that is caused by the immune
response.
Estimated as virulence statistically attributable to inﬂammatory
cytokine levels independent of parasite density.
Recovery rate,
estimated as
concentration of
inﬂammatory
cytokines
Immunological molecules such as cytokines and
cells such as macrophages recruited in response to
infection. These molecules promote parasite
clearance but cause damage.
Pro- and anti-inﬂammatory cytokine titres in the plasma at the
time of peak asexual parasite density.
Exploitation,
estimated as
parasite density
within the host
Extraction of host resources for production of
transmission-stage parasites. Empirical studies
often use within-host replication or growth rate
as a measure of exploitation.
Cumulative or peak density of asexual parasites.
Immunogenicity Per-parasite immune stimulatory effect. Intensity of stimulation of Toll Like Receptors on antigen
presenting cells.
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induced mortality, the transmission potential is less than
if the host lived, suggesting host death is a brake on viru-
lence evolution (Mackinnon et al. 2002).
However, parasite virulence encompasses damage due
to infection-induced immunopathology as well as direct
parasite-mediated exploitation (Romagnani 1996; Clark
et al. 2006; de Jong et al. 2006; Margolis and Levin 2008),
among other host and environmental factors (Frank 1996;
Little et al. 2010; Magalon et al. 2010). For example, the
characteristic anemia associated with malaria infection is
driven by a combination of destruction of infected RBCs
by parasites, as well as haemolysis (Ritter et al. 1993) and
phagocytosis (Waitumbi et al. 2000; Wickramasinghe and
Abdalla 2000; Serghides et al. 2003) of both infected and
uninfected RBCs by the immune system. In addition,
other severe malaria symptoms such as cerebral damage
are associated with overzealous infection-induced inﬂam-
matory responses (Schoﬁeld and Grau 2005). Analogous
examples of immunopathological virulence are found in a
huge array of infectious diseases (Graham et al. 2005a).
The immune response against malaria (and indeed a
wide array of pathogens) thus requires a delicate balance
to control parasites on the one hand and avoid immuno-
pathological damage on the other, in both rodent (Li
et al. 2001; Stevenson and Riley 2004) and human malaria
infection (Dodoo et al. 2002; Clark et al. 2006). The
importance of pro-inﬂammatory responses, including
tumour necrosis factor [TNF]-a, in cell- and antibody-
mediated immunity to malaria is well established (see Li
et al. 2001 and Stevenson and Riley 2004 for good reviews
in this area). However, excessive levels of pro-inﬂamma-
tory cytokines cause much of the characteristic malaria
inﬂammation and anti-inﬂammatory cytokines such as
interleukin [IL]-10 play important roles in limiting infec-
tion-induced immunopathology (Li et al. 2001; Dodoo
et al. 2002). The tight immune regulation necessary for
optimal defense against infectious agents has been likened
to the porridge sampled by Goldilocks in the home of the
three bears (Germain 2001): whereas a slow or weak
immune response risks being overwhelmed by rising para-
sitaemia—‘too cold’—an overzealous one may lead to
severe disease because of the destructive effects it exerts
on host tissue—‘too hot’. The optimal response must be
robust, rapid and properly regulated—‘just right’.
Effects of protective versus pathological immune
responses on virulence evolution
Theoreticians increasingly recognize the pivotal inﬂuence
host immunity exerts on parasite dynamics at both the
within-host and epidemiological scales and ﬁguring out
the best ways to incorporate host immunity into the
trade-off model has been the focus of much recent work
(Alizon and van Baalen 2008; Alizon et al. 2009). In
some scenarios, immune responses are assumed to be
purely protective, acting solely to decrease parasite den-
sity and thus to reduce disease severity and risk of host
death (Antia et al. 1994; Antia and Lipsitch 1997; Gan-
don et al. 2001). This type of immune system activity
alleviates the reduced transmission potential associated
with early host death. Thus, theory predicts that highly
immune host populations can maintain more virulent
parasites relative to naı ¨ve host populations (Gandon
et al. 2001). Empirical evidence from rodent malaria
infections supports this prediction, with immune selec-
tion accelerating the rate of virulence evolution
(Mackinnon and Read 2003, 2004b).
What selective pressures do pathological immune
responses exert on the trajectory of parasite virulence evo-
lution, beyond those exerted by protective immunity? The
key issue is that immunopathology can alter the relation-
ship between virulence and exploitation (including
within-host replication and/or between-host transmis-
sion). For example, excessive inﬂammation might alter
virulence-exploitation relationships by: (i) increasing the
rate of host death even when the rate of parasite killing
also increases (Graham et al. 2005a; Day et al. 2007); (ii)
disproportionately killing transmission-stage parasites; or
(iii) altering investment in transmission-stage parasites.
The applicability of these scenarios to the malaria case
study is discussed below.
Theoretical work has investigated how parasite exploi-
tation strategies should evolve in the presence of (i)
immune-mediated host death (Day et al. 2007). Accord-
ing to this theory, virulence a(e, c) comprises direct
effects (c) of exploitation (e) plus effects of immunopa-
thology f(e, c), which are in turn broken into four biolog-
ically plausible components that scale with exploitation
e(u1), with recovery rate c (u2), with their statistical
interaction ec (u3), or are independent of both (u0) (Day
et al. 2007). Immunopathology is plausibly a function of
recovery rate because both depend on the extent of
immune activation (e.g., high plasma concentrations of
pro-inﬂammatory cytokines such as TNF-a are associated
with rapid malaria clearance but elevated risk of collateral
inﬂammatory damage; Li et al. 2001; Stevenson and Riley
2004). Thus, in this framework (Day et al. 2007), overall
virulence can be represented as follows:
a(e, c)=ce + f(e, c)=ce + u0 + u1e + u2c + u3ec
= u0 +( u1 + c)e + u2c + u3ec
(below we use empirical data to estimate parameters of
the rightmost version of the equation). The theory arising
from this dissection of the causes of immunopathology
predicts that when the risk of immune-mediated host
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ple, when u1 or u3 > 0), natural selection favors parasites
with prudent within-host exploitation strategies because
of the increased survival cost of exploitation (Day et al.
2007). On the other hand, if immunopathological host
death is independent of exploitation (e.g., when
u1 = u3 = 0), then selection is expected to lead to
increased virulence. In this scenario, immune-mediated
host death has the effect of increased background mortal-
ity—i.e., the host will die regardless of what the parasite
does (Long et al. 2008a)—which weakens the survival
beneﬁt of prudent exploitation and may select for
increased virulence (Day et al. 2007). The trade-off
hypothesis thus can readily accommodate immunopathol-
ogy, and the predicted evolutionary trajectories depend
upon the mechanism(s) by which immunopathology is
generated.
The association of host-damaging immune responses
with mechanisms that (ii) disproportionately kill- or (iii)
alter investment in transmission-stage parasites has not to
our knowledge been explored explicitly by theoreticians,
but could also exert powerful effects on parasite virulence
evolution by altering virulence-transmission relationships.
At a minimum, (ii) should decrease transmission and (iii)
should increase transmission, for a given level of viru-
lence. For example, certain pro-inﬂammatory cytokines
implicated in driving malaria virulence are also associated
with gametocyte killing (Naotunne et al. 1991, 1993). If
immunopathological virulence is associated with gameto-
cyte death, then the relationship between virulence and
transmission could become negative, thus defying a major
assumption of basic theory (Anderson and May 1982).
On the other hand, immunopathology could increase
transmission potential if it increases the proportion of
asexual parasites which become committed to the sexual
stage. It has long been observed that commitment of
malaria asexuals to gametocytes is inﬂuenced by their
environment (Carter and Miller 1979). Indeed, ‘stress
cues’ in the form of host immune responses against asex-
ual parasites have been suggested to correlate with altered
gametocyte loads and below we discuss one study where
we ﬁnd such evidence (Long et al. 2008b), in contrast to
a previous study which did not (Buckling and Read
2001). If inﬂammation triggers gametocytogenesis, the
positive relationship between virulence and transmission
assumed by basic theory would be maintained along with
the predictions arising thereof.
We have experimentally examined each of these possi-
ble selective effects of pathological immune responses in
rodent malaria. The majority of previous work on protec-
tive and pathological responses to malaria (for example,
as reviewed by Li et al. 2001) focused on a single parasite
clone and did not investigate transmission potential or
other proxies for parasite ﬁtness. We therefore undertook
a series of experiments in which we explored whether
immune factors central to the protection-pathology bal-
ancing act help to determine the virulence induced during
infection with genetically distinct malaria parasites, and if
so, what effect this may have on parasite ﬁtness. We used
the same rodent malaria system for which the adaptive
trade-off hypothesis has empirical support (Mackinnon
and Read 2004a); P. chabaudi in a resistant strain of
laboratory mice C57BL/6 (Stevenson et al. 1982). To seek
evidence of parasite genetic differences in immunopatho-
logical virulence and transmission determinants on which
selection might operate, we used a toolbox of between
four and eight genetically distinct P. chabaudi clones—
which have been shown to differ in the in vivo virulence
they induce (Mackinnon and Read 1999a; Ferguson et al.
2003)—and tracked asexual and sexual parasite densities,
virulence, and systemic inﬂammation during infection
(see Glossary for traits measured). Furthermore, we
experimentally manipulated the host immune response
itself, thanks to the availability of suitable reagents for
laboratory mice (Li et al. 2001; Stevenson and Riley
2004). Indeed, via the systemic administration of immu-
nological reagents we were able to push hosts in both
pro-inﬂammatory (Long et al. 2008a) and anti-inﬂamma-
tory (Long et al. 2006, 2008b) directions.
Before outlining our published results in light of possi-
bilities (i)–(iii), we describe the statistical dissection of
immunopathological mechanisms—for example, the over-
production of pro-inﬂammatory cytokines—from direct
effects of parasite replication in determining variation in
virulence. Such methods also enable identiﬁcation of
exploitation-dependent versus exploitation-independent
immunopathology, which is critical to predicting evolu-
tionary trajectories (Day et al. 2007).
Statistical separation of immune- from direct
parasite-mediated virulence
An evolutionary immunologist interested in how immuno-
pathology affects virulence evolution must distinguish
immune- from directly parasite-mediated host damage.
Once data on parasite densities, inﬂammation, and viru-
lence are obtained (see Glossary), statistical separation of
the causes of virulence is achievable using analysis of
covariance (Graham et al. 2005b). Predictor variables may
include immune manipulation, parasite genotype, and their
interaction, as well as linear and quadratic terms for the
density of both parasites and pro-inﬂammatory cytokines.
For example, we found that the characteristic viru-
lence of parasite genotypes positively correlated with the
inﬂammatory response induced during the acute phase
of infection (Long et al. 2006). To determine whether
Long and Graham Immunopathology and virulence evolution
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cation rates among clones (Mackinnon and Read
1999a), data were analyzed with maximum parasitaemia
as a covariate (though we thereafter used parasite den-
sity; see Glossary). More virulent malaria clones induced
a greater plasma TNF-a response relative to their less
virulent counterparts, even when any linear and (in this
case non-signiﬁcant) quadratic effects of asexual parasite
load were statistically controlled for (Long et al. 2006).
Thus, we found evidence that the clones differed signiﬁ-
cantly in the per-parasite inﬂammation they induced.
Whether P. falciparum malaria exhibits similar genetic
diversity is not yet clear—for example see (Corrigan and
Rowe 2010)—but parasite genetic differences in immu-
nopathological virulence have been demonstrated for
various other infections, including protozoa (Kebaier
et al. 2001; Mordue et al. 2001) and viruses (de Jong
et al. 2006). To directly test whether the propensity to
induce a large inﬂammatory response was driving some
P. chabaudi clones to higher virulence, we applied anti-
inﬂammatory treatments—i.e., we blocked TNF-a
signaling through the administration of soluble TNF-a
receptor fusion protein, TNFR-Ig, early during infec-
tion—which reduced the virulence of all clones, inde-
pendent of parasite load (Long et al. 2006, 2008b). Thus
although there was variation among clones in the induc-
tion of inﬂammation, TNF-a signaling contributed to
the virulence of all clones.
Here, to illustrate how such data may be aligned with
theory to estimate the contribution of immunopathology
to virulence evolution (Day et al. 2007), we have com-
bined and re-analysed our published data on the viru-
lence of four malaria clones in un-manipulated versus
anti-inﬂammatory treated hosts (Long et al. 2006, 2008b).
However, several caveats are essential from the outset. We
agree in principle that it should be achievable to study
immunopathology-induced mortality per se (Day et al.
2007), but our data were not collected for that purpose.
Instead, our data comprise all-cause mortality and mor-
bidity. For example, we measured RBC density daily and
observed substantial declines during acute malaria, but we
did not partition the anaemia into portions attributable
to lysis of infected RBCs versus bystander killing (Wait-
umbi et al. 2000; Wickramasinghe and Abdalla 2000;
Serghides et al. 2003) or removal from circulation of
uninfected RBCs (Safeukui et al. 2008) by the immune
system. Such partitioning is possible via analysis of para-
site population dynamics (Haydon et al. 2003) or detailed
mechanistic analysis (Chang and Stevenson 2004). It
would also be possible, in future experiments, to measure
virulence traits that more purely represent immunopa-
thology—for example through quantiﬁable inﬂammatory
damage to the brain of malaria-infected mice (Amante
et al. 2010). But to make use of the existing all-cause
virulence data, we redistribute terms from Day et al.’s
theoretical development (Day et al. 2007) as outlined
above, to generate the following expression for all-cause
virulence: a(e, c)=u0 +( u1 + c)e + u2c + u3ec. The
dual coefﬁcients for exploitation e represent dual contri-
butions of immunopathology u1 and direct damage c to
the per-parasite virulence (see also Little et al. 2010),
though the two are often indistinguishable in practice.
Finally, we used peak parasite density as our proxy for
parasite exploitation and peak plasma pro-inﬂammatory
cytokine concentration as our proxy for recovery rate (see
Glossary). The latter is justiﬁed by the common observa-
tion that elevated pro-inﬂammatory cytokines are associ-
ated with rapid malaria clearance (Li et al. 2001;
Stevenson and Riley 2004). Both proxies accord with the
empirical expectations of (Day et al. 2007) and are ren-
dered essential by the available data, even if the proxies
are imperfect: the precise variables that are theoretically
interesting are often empirically inaccessible.
With these caveats, we proceeded with statistical analy-
sis as described in Box 1. Our analyses of anaemia and
cachexia (Table 1A and B, respectively within Box 1) par-
titioned virulence increasing with parasite density from
that increasing with inﬂammation. Even when virulence
did increase with parasite density (and, in some cases,
quadratic parasite density), some virulence independently
increased with inﬂammation. Box 1 further illustrates
diversity among clones in the relative importance of
the two mechanisms. For example, whereas virulent clone
AJ causes RBC loss via both exploitation-dependent and
-independent mechanisms, virulent clone BC appears to
cause virulence independent of exploitation, but strongly
dependent upon the inﬂammatory response induced (for
example, 3.3 billion RBCs were lost for every log increase
in picograms of pro-inﬂammatory cytokines per milliliter
of plasma). Overall, clones exhibited signiﬁcant variation
in the slopes of the relationships described (see Box 1). If
further empirical data showed that immunopathology
(and not just total virulence) scaled with exploitation for
the majority of malaria genotypes in the host type most
important for transmission (see below), then natural
selection would be predicted to reduce malaria virulence
(Day et al. 2007).
How much parasite transmission is gained or lost
in hosts with immunopathology?
The transmission potential of rodent malaria parasites
can also be empirically estimated (Mackinnon and Read
1999a). Indeed, the theoretician’s deﬁnition of exploita-
tion comprises production of transmission stage parasites
(Glossary). Therefore, to elucidate potential selective
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malaria transmission potential for hosts receiving pro-
inﬂammatory, null, and anti-inﬂammatory treatments.
As outlined above, one way immunopathological viru-
lence can affect parasite ﬁtness and hence the trajectory
of virulence evolution is by (i) increasing the rate of host
mortality. To explore this scenario, we experimentally
reduced activity of the cytokine interleukin [IL]-
10—which helps prevent immune hyperactivity during
malaria infection (see Fig. 1 and Li et al. 2001; Stevenson
and Riley 2004)—and in doing so made immunopathol-
ogy the primary cause of virulence (Long et al. 2008a).
Speciﬁcally, neutralizing IL-10 signaling expedited time-
to-death for eight P. chabaudi genotypes, and death cur-
tailed transmission potential (Long et al. 2008a). Using
similar analyses to those presented in Box 1, we statisti-
cally investigated whether linear or quadratic effects of
asexual parasite load, the pro-inﬂammatory cytokine
TNF-a, or key morbidity measurements explained
variation in mortality rates. We found that parasite
Box 1. An illustration of how the contributions to virulence of exploitation (proxy: parasite density) and recovery rate (proxy: inﬂammation)
can be statistically distinguished.
Data are drawn from experiments on rodent malaria (Long et al. 2006, 2008b), in which (Table 1 A) anemia (maximum RBC loss compared to
initial RBC density) and (1B) cachexia (maximum loss of body mass compared to initial mass) were measured. Coefﬁcients of the linear model
for virulence (i.e., slopes) were calculated within treatment type (unmanipulated versus anti-inﬂammatory) based upon the framework of Day
et al. (2007). Given the limited statistical power of this analysis, priority was given to estimating the following terms critical to trajectories of
virulence evolution: u1 + c describes how virulence relates to exploitation; u2 describes how virulence relates to recovery rate (see text for
details plus justiﬁcation of proxies). Linear and quadratic parasite density, inﬂammation, and their interactions with genotype were ﬁtted simul-
taneously as ﬁxed factors, with parasite genotype as a random effect. Minimal models were obtained, and included no quadratics. In unma-
nipulated hosts, estimates for u1 + c (F3,116 = 3.26; P = 0.024) and u2 (F3,116 = 4.69; P = 0.0039) varied signiﬁcantly among genotypes for
anemia. Estimates for u2 exhibited a trend for variation among genotypes for cachexia (F3,116 = 2.05; P0.11).
Data were then broken down by clone within treatment type. Linear and quadratic terms for parasite density and inﬂammation were simul-
taneously ﬁtted as ﬁxed explanatory variables for the virulence response variables. Initially, intercepts were not ﬁtted, to conserve statistical
power for this illustrative analysis. Estimated slopes in boldface type in Tables 1 A (for anaemia) and 1B (for cachexia) differed signiﬁcantly
from zero in minimal models; P values appear in parentheses. Models were then re-run with intercepts ﬁtted. This led to similar results, except
that quadratic parasite density was never a signiﬁcant contributor to virulence, and all P values increased. However, of the 16 slopes that dif-
fered signiﬁcantly from zero in the original analysis, only 5 lost signiﬁcance once the intercepts were ﬁtted. These are reﬂected in the P-values
of the original analysis, presented below. Analysis was conducted in PROC MIXED for SAS Systems 9.1.
Table 1. (A) Peak anaemia (loss of red blood cell (RBC) density; in 10
9/mL) (B) Peak cachexia (loss of body mass; in grams).
Parasite genotype Unmanipulated hosts Anti-inﬂammatory hosts
A
u1 + c (RBCs lost
per log increase in
parasite density)
u2 (RBCs lost
per log increase in
pro-inﬂammatory
cytokines)
u1 + c (RBCs lost
per log increase in
parasite density)
u2 (RBCs lost
per log increase in
pro-inﬂammatory
cytokines)
AJ (N = 31; 21) 4.7 (0.0028)
Q 2.3 (<0.0001)
Q 8.5 (<0.0001) 3.0 (<0.0001)
AS (N = 21; 9) 5.5 (0.074) 2.3 (<0.0001) 7.5 (0.039) 1.5 (0.030)
BC (N = 16; 5) 0 (0.5) 2.9 (0.0001) NE (N too small)
CW (N = 18; 5) 6.2 (0.026)
Q 1.5 (0.0049)
Q NE (N too small)
B
u1 + c (grams lost
per log increase
in parasite density)
u2 (grams lost
per log increase in
pro-inﬂammatory
cytokines)
u1 + c (grams lost
per log increase in
parasite density)
u2 (grams lost
per log increase in
pro-inﬂammatory
cytokines)
AJ (N = 31; 21) 1.9 (0.036)
Q 1.1 (<0.0001)
Q 2.7 (0.063) 1.5 (<0.0001)
AS (N = 21; 9) 0 (0.5) 1.1 (0.0048) 0 (0.9) 0 (0.3)
BC (N = 16; 5) 0 (0.6) 1.7 (0.0001) NE (N too small)
CW (N = 18; 5) 2.0 (0.13) 0.5 (0.012) NE (N too small)
N = number of mice per treatment group infected with each parasite genotype; NE = not estimated;
Q = quadratic parasite density (PD) was a
signiﬁcant contributor to virulence; the slope and P value shown in such cases are for linear PD and inﬂammation with quadratic PD retained
in the model; slopes in bold differ signiﬁcantly from zero.
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P = 0.3). Instead, the plasma concentration of TNF-a
during acute infection and minimum body-temperature
signiﬁcantly predicted survival time, across treatment
groups and independent of parasite load: higher TNF-a
(F1,52 = 9.42, P = 0.003) and greater temperature losses
(F1,52 = 30.7, P < 0.001) were associated with a quicker
time-to-death. This is not surprising as mortality actually
increased with decreasing parasite burden in IL-10 neu-
tralized hosts (Long et al. 2008a), and the over-produc-
tion of pro-inﬂammatory cytokines can mediate a toxic
shock-like syndrome (Florquin et al. 1994; Holscher et al.
2000). Similarly, the enhanced disease severity of mice
deﬁcient in IL-10 and infected with the parasites Trypano-
soma cruzi (Hunter et al. 1997), Toxoplasma gondii (Gaz-
zinelli et al. 1996), or Helicobacter hepaticus (Kullberg
et al. 1998) did not correlate with increased parasite load,
but rather with an overzealous inﬂammatory response. If
hosts with strong pro-inﬂammatory responses are com-
mon and if they die without transmitting infections in
nature, this should affect virulence evolution. The direc-
tion of selection depends upon whether immunopathol-
ogy positively correlates with exploitation in such hosts
(Day et al. 2007).
Beyond causing host death, immunopathology might
also affect the direction of malaria virulence evolution
by (ii) killing or (iii) altering investment in gametocytes.
In other words, inﬂammatory immune responses can
disproportionately affect gametocytes, independent of
asexual parasite density (Fig. 1). We found that the
anti-inﬂammatory treatment by which we neutralised
TNF-a increased transmission potential over the dura-
tion of infection (Long et al. 2008b), independent of
asexual parasite load and regardless of P. chabaudi geno-
type (see Glossary for details of traits measured).
Indeed, over the course of infection TNFR-Ig treated
mice had on average 44% more gametocytes than con-
trol mice and, importantly, were more infectious to
mosquitoes (Long et al. 2008b). Commitment and devel-
opment of asexuals to gametocytes takes 24–48 h in
P. chabaudi (Carter and Walliker 1975). The speed with
which TNF-a neutralization increased gametocyte densi-
ties—within 4 h of treatment—thus effectively excluded
gametocyte conversion as the main factor driving
increased gametocyte load. Rather, the increase in game-
tocyte density and infectivity in hosts receiving anti-
inﬂammatory treatment may be explained by protection
of gametocytes from immune attack (Naotunne et al.
1991, 1993). In agreement with our ﬁndings, excessive
induction of TNF-a in human malaria has been pro-
posed to contribute to severe disease on the one hand
(Clark et al. 2004, 2006), and reduce infectiousness to
mosquitoes on the other (Karunaweera et al. 1992).
These gametocidal effects (ii) of TNF-a suggest that
inﬂammation may contribute to virulence while reduc-
ing transmission potential.
At the same time, gametocyte production is highly sus-
ceptible to environmental changes (Carter and Miller
1979). For example, it has been hypothesized that host
immune responses may trigger gametocytogenesis (Dyer
and Day 2000). Although a previous direct test of this
hypothesis failed to ﬁnd supporting evidence (Buckling
and Read 2001), we have additional results which suggest
a pro-inﬂammatory environment is associated with
gametocytogenesis cues for some malaria genotypes. The
experimental enhancement of immunopathology during
infection via IL-10 neutralisation incurred a uniform ﬁt-
ness cost to all P. chabaudi clones by reducing the lifetime
transmission potential via host death (Long et al. 2008a),
as described above. However, early in infection, parasite
genotype was important in determining how increases in
inﬂammation affected the density of transmission-stage
parasites; whether inﬂammation cued gametocytogenesis
depended on P. chabaudi parasite genotype (Long et al.
2008a). More generally, it is possible that parasites experi-
ence trade-offs for inducing inﬂammation, if the costs of
provoking pro-inﬂammatory responses at one point in
Figure 1 Tumour necrosis factor (TNF)-a and other pro-inﬂammatory
cytokines help govern both virulence and transmission of malaria par-
asites. Here we want to illustrate how an increased understanding of
the relationship between virulence mechanisms (in this case immuno-
pathological virulence) and how they relate to parasite transmission
could have major implications for virulence evolution. ‘)ve’ denotes
an inhibitory effect, while ‘+ve’ denotes synergy. Arrows in bold are
considered especially potent effects. The gametocidal effects of TNF-a
can reduce transmission potential (Long et al. 2008b), but un-
regulated or excessive levels can lead to immunopathological virulence
(Long et al. 2006, 2008b). These data show that virulence and trans-
mission are not always positively correlated. Such new information
can be incorporated into the trade-off model to provide quantitative
answers to how virulence might evolve (Day et al. 2007).
Immunopathology and virulence evolution Long and Graham
284 ª 2011 Blackwell Publishing Ltd 4 (2011) 278–291infection are outweighed by the beneﬁts at other time
points.
These empirical results for gametocyte density are
corroborated by a new, combined analysis of the duration
of gametocyte positivity across the three treatment groups
(see Glossary for details of traits measured). Figure 2 illus-
trates the effects of host death and each of our immune
manipulations on the duration of gametocytemia, and
argues that both death and host heterogeneity in the
inﬂammatory state may affect malaria transmission poten-
tial. For example, anti-inﬂammatory treatment increased
the duration of gametocytaemia by 1.53 ± 0.33 days on
average, an effect comparable in magnitude (though oppo-
site in sign) to the effects of host death on transmission
()1.22 ± 0.28 days on average; Fig. 2). Overall, hosts
presenting an anti-inﬂammatory milieu were infectious for
longest, while ‘pro-inﬂammatory hosts’ had the briefest
infectious periods. These effects were independent of host
death (Fig. 2) and asexual parasite density (Long et al.
2008a,b), although we acknowledge that the duration of
asexual parasitaemia would probably affect duration of ga-
metocytaemia during chronic infections (Bell et al. 2006).
Collectively, our empirical results thus far suggest that
immunopathological virulence has the potential to strongly
affect malaria ﬁtness, via increased host death rates (Long
et al. 2008a) and/or via associations with altered produc-
tion (Long et al. 2008a) or survival (Long et al. 2008b) of
transmission-stage parasites themselves.
Immunopathology and virulence evolution;
insights from malaria
Reasons why immunopathology might shape the evolu-
tion of malaria virulence are summarized in Table 2. In
essence, the extra mortality imposed by immunopathol-
ogy may inﬂict an extra cost of virulence, which cannot
be explained by host exploitation alone. Such extra death
may not be positively related to host exploitation or
transmission and may alter the cost/beneﬁt ratio of viru-
lence. Indeed, for P. chabaudi, the capacity of inﬂamma-
tion to kill both hosts and gametocytes may generate
negative virulence-transmission relationships (or, at a
minimum, alter transmission potential for a given level of
virulence). Furthermore, the suite of genotypes studied
here exhibits relevant genetic variation and thus raw
material for natural selection: parasite genotype shapes
the amount of inﬂammation induced, the extent to which
virulence positively correlates with parasite density, and
gametocytogenesis cues. These traits could in turn affect
the outcome of competition within hosts. For example,
genotypes that strongly induce inﬂammation and transmit
efﬁciently in the face of high concentrations of cytokines
such as TNF-a may outcompete genotypes that would
otherwise (i.e., in the context of weak inﬂammatory
responses) achieve high within-host densities. Virulent
immune-provoking behaviours and enhanced immune
resistance have been proposed as tactics adopted by
invading pathogens to eliminate competitors (Brown
et al. 2008). Indeed, within host competition among
genotypes can either increase or decrease immediate viru-
lence and is also a major driver of virulence evolution
(Mideo 2009).
Before these ﬁndings (Table 2) are used to predict evo-
lutionary trajectories with conﬁdence, however, much
work remains to be done. For example, the simultaneous
contributions of host and parasite genotypes (Little et al.
2010) to immunopathology would be important to
Figure 2 Inﬂammatory status of the host shapes rodent malaria
transmission potential. In vivo treatments extended the range of
inﬂammatory phenotypes exhibited during Plasmodium chabaudi
infection. We applied two types of treatments: ‘anti-inﬂammatory’ in
the form of TNFR-Ig which decreased immunopathology (Long et al.
2008b), or ‘pro-inﬂammatory’ treatments in the form of IL-10R (Long
et al. 2008a) which enhanced immunopathology. We always included
a control (unmanipulated) group. In a combined data analysis, we
found that the number of days gametocyte positive (an estimate of
the duration of infectiousness) was strongly affected by host inﬂam-
matory status (F2,207 = 25.1; P < 0.0001). Hosts receiving anti-inﬂam-
matory treatment were gametocyte positive for longest, followed by
un-manipulated hosts and then hosts receiving pro-inﬂammatory
treatment (Tukey-corrected pair-wise differences between anti-inﬂam-
matory hosts and both other types P < 0.0001; un-manipulated and
pro-inﬂammatory mice also differed signiﬁcantly, P = 0.0011). Death
of the host further reduced gametocyte positivity by an average of
1.2 ± 0.3 days (F1,207 = 19.0; P < 0.0001), but did not interact signiﬁ-
cantly with treatment type (P  0.4). Thus, the duration of gameto-
cyte patency associated with inﬂammatory status was independent of
the signiﬁcant infection-shortening effects of host death. Test statistics
and P-values for main effects come from the minimal model, including
a random effect for clone, run in PROC MIXED for SAS Systems 9.1.
Long and Graham Immunopathology and virulence evolution
ª 2011 Blackwell Publishing Ltd 4 (2011) 278–291 285explore, and tolerance traits whereby hosts alleviate
the ﬁtness effects of a given parasite burden may be
critical (Raberg et al. 2009). It would also be of great
interest to estimate u3, the coefﬁcient of the statistical
interaction between exploitation and recovery rate (Day
et al. 2007), and to obtain ﬁrmer estimates of the other
coefﬁcients in a better-powered analysis in future. Such
analysis of a human malaria species would be ideal, and
the literature suggests that suitable data exist (Akanmori
et al. 2000). Finally, it would be of interest to explore
the effects of immunopathology upon trajectories of viru-
lence evolution that are predicted by theories other than
the trade-off model (Levin and Bull 1994; Alizon et al.
2009).
For now, the outcome of immunopathology for malaria
virulence evolution remains difﬁcult to predict. The
extent to which malaria in the laboratory represents
malaria in the ﬁeld, plus the relative importance of
inﬂammation- versus exploitation-dependent immuno-
pathological virulence, will determine whether we expect
increased or decreased ESS virulence due to immunopa-
thology. For example exploitation-dependent immunopa-
thology, could select for decreased virulence (Day et al.
2007), by decreasing parasite immunogenicity and/or
replication rate. However, protective immune responses
against malaria impose the opposite selection pressure
(Mackinnon and Read 2004b), as does immunopathologi-
cal virulence that is independent of exploitation (Day
et al. 2007). The relative strengths of these potentially
conﬂicting effects of immunity remain to be elucidated.
Furthermore, it will be essential to consider the role of
host heterogeneity in the evolution of malaria virulence
(Mackinnon and Marsh 2010). Immunopathology is likely
to be highest in non-immune individuals (for example,
children in areas of high malaria transmission) whose
immune response is not yet primed against malaria infec-
tion and who might suffer more immunopathology as a
result of non-speciﬁc anti-parasitic clearance mecha-
nism(s), such as the systemic induction of inﬂammatory
host cytokines (Grau et al. 1989). Theoretical studies have
revealed that the cost of host death is greatest in children
as they are both more likely to die- and transmit- malaria
parasites than their adult counterparts (Mackinnon and
Marsh 2010). An immunopathological arm to virulence
in non-immune hosts has been shown (Schoﬁeld and
Grau 2005) and in such a host population, mutant para-
sites that are less immunogenic would be expected to be
favored by natural selection as highly immunogenic
strains would be removed by host death. But host popu-
lations are a mixture of host ‘types’ and because parasites
do not chose their hosts and evolve to suit the average
host (Mackinnon and Marsh 2010), the optimal level of
virulence which evolves in a population will ultimately
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semi-immune hosts in the population. Thus, the results
depicted in Fig. 2, although suggestive of a key role of
host heterogeneity in malaria transmission potential, must
be placed ﬁrmly in an epidemiological perspective before
the full implications become clear.
As far as we are aware, ours is the ﬁrst empirical evi-
dence supporting malaria genetic variation in both the
induction of inﬂammation that contributes to virulence
(Long et al. 2006) and in the response to inﬂammation
that affects gametocytogenesis and hence transmission
potential (Long et al. 2008a). Indeed, outside of malaria,
no studies we could ﬁnd explicitly examine the transmis-
sion consequences of genetic differences in immunopath-
ological virulence. More data are required in both human
malaria and other parasitic diseases to determine whether
the immunopathology, virulence, transmission relation-
ships are encoded by parasite genes, and to determine
how much virulence variation exists in the ﬁeld. It is our
contention that expanding the trade-off theory to incor-
porate immunopathology, coupled with empirical studies
which test that theory will help improve our understand-
ing of the evolution of parasite virulence. For example,
investigating whether immunopathological virulence
schedules (for example, see Table 1 within Box 1) differ
between distinct parasite strains and if so, what the ﬁtness
consequences are for transmission potential. Such studies
would allow more informed decisions to be made regard-
ing medical interventions which would be optimal for
long term disease control.
Evolutionary responses to malaria interventions
that alter immunopathology
A public health goal for malaria treatments is to reduce
the infectious reservoir, while the reduction of disease
severity and prevention of death is a major clinical goal.
Our results suggest that interventions aimed at reducing
symptoms of disease but not parasites, might not be ben-
eﬁcial at the population level. Reducing immunopatho-
logical disease severity in individual hosts could in fact
increase transmission potential in the short term (Long
et al. 2008b). When immunopathology arises indepen-
dently of exploitation, this might increase evolved viru-
lence in the longer term (Day et al. 2007), in keeping
with predictions for malaria evolution in response to
anti-disease vaccines that alleviate the cost of virulence
for parasites (Gandon et al. 2001; Williams 2009). In the
past, the association of elevated serum TNF-a levels with
malaria disease severity (Grau et al. 1989; Kwiatkowski
1990) led to the use of anti-TNF-a therapies for acute
human malaria. These therapies signiﬁcantly reduced
body temperature (Kwiatkowski et al. 1993; van
Hensbroek et al. 1996; Looareesuwan et al. 1999), but
increased the severity of neurological sequelae (van
Hensbroek et al. 1996) and are not currently recom-
mended because of lack of consistent clinical beneﬁt.
However, current work developing anti-toxin malaria
vaccines may raise similar concerns about transmission,
due to downstream effects on TNF-a. For example, anti-
GPI vaccines aim to neutralise the toxin which triggers
the release of TNF-a and related cytokines from host
immune cells (Schoﬁeld et al. 2002).
Just as vaccine evaluation has been proposed to include
evolutionary assessments—such as effects of vaccination
on parasite transmission (Read and Mackinnon
2008)—we feel therapies which target immune-mediated
virulence should likewise evaluate evolutionary risk.
Routine monitoring of how any new anti-malaria therapy
affects gametocyte density as well as disease severity would
allow more informed decisions to be made regarding the
wide-spread application of putative anti-malaria drugs.
Where medical interventions fail to prevent parasite trans-
mission, archiving of parasites to provide a detailed
account of parasite diversity pre-, during- and post-treat-
ments might help identify potential areas of concern and
point towards the optimal strategy for control and
ultimately parasite eradication (Read and Mackinnon
2008). Finally, empirical studies examining the within-host
dynamics and transmission potential of pathogens in
response to drug or vaccine pressure provide a fruitful
avenue with which to investigate evolution of vaccine
escape/facilitation (Grech et al. 2008; Long et al. 2010) or
drug-resistance (Wargo et al. 2007; Huijben et al. 2010)
and may also help make more informed decisions on
optimal intervention for disease control in the presence of
immunopathology.
Future directions and outlook
The current lack of cross talk between molecular and evo-
lutionary biologists regarding the causes of virulence and
how they affect transmission makes predicting the trajec-
tory of virulence evolution difﬁcult. A more in-depth
knowledge of the biological system at hand might very
well lead to better quantitative predictions (Gandon et al.
2001), and here the trade-off is open to addition of much
biological detail (and there is an abundance of biomedical
knowledge available). Indeed, a deeper understanding of
the mechanisms driving parasite virulence will help deﬁne
relationships between parasite traits of key importance to
the trade-off theory (Frank and Schmid-Hempel 2008).
Work focused on P. falciparum show how layers of bio-
logical detail can be added to the trade-off model in
order to provide a framework that can predict more
quantitative outcomes (Alizon and van Baalen 2005) and
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(Mackinnon and Marsh 2010). Tests of the nature and
strength of relationships between parasite-encoded viru-
lence (of any mechanism) and transmission are well
within grasp of many empiricists. Such tests would go a
long way in elucidating which selection pressures are the
most powerful drivers of evolutionary change and what
interventions are optimal for long-term parasite control.
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